Some studies have reported that GCH1-mediated de novo synthesis of BH4 promotes CRC cell growth; and inhibition of GCH1 represses CRC progression in vitro and in vivo (Pickert et al., 2013). This evidence concerns the gene GCH1 and colorectal carcinoma.